GLP1 Protocol
vaccinesBrand Guide

Zepbound Vial vs Pen

Same drug, two delivery formats. The single-dose pen is the standard pharmacy product. The single-dose vial is a lower-cost option through LillyDirect — with a different injection routine and a few practical trade-offs.

Zepbound (tirzepatide) ships in two formats. The single-dose auto-injector pen is what most prescriptions default to — one device per weekly dose, with a press-and-hold injection routine. The single-dose vial is a newer format, sold through Eli Lilly's direct-to-patient program (LillyDirect) at a lower self-pay price. The vial is the same tirzepatide at the same dose strengths, but it requires you to draw the medication into a separate syringe and inject it yourself.

The format choice does not change the medication, the schedule, the titration ladder, or the result. It changes the price, the supply channel, and the day-to-day injection routine. For most people the decision comes down to two things: whether insurance covers the pen at a reasonable copay, and whether you are comfortable using a syringe.

This guide walks through the practical differences — cost, dose strengths offered in each format, injection technique, storage — and the questions most people have before deciding.

At a glance

Single-dose pen

  • Format: Pre-filled auto-injector, single use
  • Dose strengths: 2.5, 5, 7.5, 10, 12.5, 15 mg
  • How to use: Press flat on skin, push button, wait for two clicks
  • Channel: Standard retail pharmacies, with insurance
  • Cost: Insurance dependent; list price approximately one thousand dollars per month
  • Needle: Built into the device, never seen

Single-dose vial

  • Format: Glass vial with rubber stopper, one dose per vial
  • Dose strengths via LillyDirect: 2.5, 5, 7.5, 10 mg
  • How to use: Draw with separate syringe, inject subcutaneously
  • Channel: LillyDirect self-pay program, shipped to your door
  • Cost: Lower monthly self-pay price than the pen list price
  • Needle: Separate syringe; you handle and dispose of it

What is identical between the formats

The molecule is the same. Whether you choose the pen or the vial, you are injecting tirzepatide at the same dose strengths, with the same once-weekly schedule, the same titration ladder (2.5 mg starter for four weeks, then 5, 7.5, 10, 12.5, or 15 mg), and the same expected weight-loss and side-effect profile. Pharmacokinetics are equivalent — there is no clinical reason one format would work better or worse than the other.

The administration target is the same. Both formats are subcutaneous injections into the abdomen, front of the thigh, or back of the upper arm. The site-rotation rules, the room-temperature pre-warming, and the storage rules (refrigerated before use, up to 21 days at room temperature after first taking out) are all the same.

The clinical guidance is the same. Side effects, contraindications, drug interactions, and what to do for a missed dose do not depend on whether you used a pen or a vial. The label, the warnings, and the manufacturer's medical guidance apply to both formats identically.

Where the formats differ

The cost structure is the biggest practical difference. The pen is the format most insurance plans cover, so people with weight-loss coverage usually pay a copay closer to twenty-five to one hundred dollars per month. Without coverage, the pen's list price is significantly higher. The vial format launched specifically as a self-pay product through LillyDirect — it ships at a lower per-month cost than the pen list price, designed for cash-pay patients who do not have weight-loss benefits.

The injection routine is the other practical difference. The pen is a one-step device: uncap, press the clear base flat against the skin, unlock the lock ring, press the purple button, and hold until you hear the second click. The vial requires you to draw the prescribed dose into a separate syringe (typically a 0.5 mL or 1 mL insulin-style syringe), tap out air bubbles, and inject manually. People who have used insulin or other syringe-based injections find it familiar; people who have never used a syringe usually find the pen easier.

Dose strengths available in each format differ slightly. The pen ships in all six strengths (2.5, 5, 7.5, 10, 12.5, 15 mg). The LillyDirect vial program offers a subset (2.5, 5, 7.5, 10 mg as of launch), so people on 12.5 or 15 mg maintenance doses may need to stay on the pen — or transition through the available vial strengths and pen for the highest doses.

Practical decision framework

credit_card

Insurance first

If your plan covers Zepbound at a reasonable copay, the pen is usually the simpler choice. The vial is built for the self-pay market.

vaccines

Comfort with a syringe

If you have used insulin pens or syringes before, the vial is approachable. If a syringe makes you uneasy, the auto-injector pen removes the learning curve entirely.

stairs

Check your dose ladder

LillyDirect vials currently top out at 10 mg. If your maintenance dose is 12.5 or 15 mg, the pen remains your supply channel for those strengths.

The vial injection routine in plain terms

For people choosing the vial, the basic routine is: pull the vial from the fridge 15 to 30 minutes before injecting so it reaches room temperature, wipe the rubber stopper with an alcohol swab, draw the prescribed volume into a sterile syringe (your provider will give you the exact volume for your dose), tap out air bubbles, choose a clean injection site, and inject subcutaneously at a 90-degree angle. Hold for a count of five after the plunger is fully depressed, then dispose of the syringe in an FDA-cleared sharps container.

The volume you draw depends on the dose strength of the vial and the prescribed dose. Most LillyDirect vials are formulated so the entire vial is one dose — you draw all of it, no math required. Your prescribing provider or pharmacist confirms this when the vials are shipped. Never improvise the volume.

Vials, like pens, can sit at room temperature (below 86°F / 30°C) for up to 21 days after first removal from the fridge — though most people inject within hours of opening because each vial is single-use. Vials must not be frozen. Once a syringe has touched the vial, the vial is considered open and should be used immediately or discarded.

Common questions

Common Concerns

Is the vial weaker than the pen?expand_more
No. Both formats contain the same tirzepatide at the same labeled dose strength. A 5 mg vial and a 5 mg pen deliver the same 5 mg subcutaneous dose. Pharmacokinetic equivalence is built into the formulation.
Why is the vial cheaper than the pen?expand_more
The pen is a more complex device — the auto-injector hardware costs more to manufacture and is priced for the insurance market. The vial is a simpler primary container and is sold through LillyDirect at a lower self-pay price aimed at cash-pay patients without weight-loss coverage.
Can I switch from pen to vial mid-course?expand_more
Yes, with prescriber guidance. The dose stays the same; only the delivery format changes. Many people switch because their insurance situation changes or because the LillyDirect price becomes a better fit.
Do I need a prescription for the vial?expand_more
Yes. LillyDirect dispenses the vials through a pharmacy partner and requires a valid prescription, just like any other Zepbound product. The self-pay channel does not bypass the prescription requirement.
Is the vial available outside LillyDirect?expand_more
As of launch, the single-dose vial format is exclusive to LillyDirect. Standard retail pharmacies dispense the pen format. Availability has shifted over time, so confirm with your prescriber what is currently in stock through which channel.

Keep exploring

Browse all dosing guides or read the Zepbound starting guide for the first-month walkthrough.